Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06 Septiembre 2023 - 6:00AM
Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage
biopharmaceutical company discovering and developing clinically
differentiated small molecule therapeutics targeting fundamental
biological pathways of cancers, today announced that Kimberly
Blackwell, M.D., Chief Executive Officer of Zentalis, will
participate in a fireside chat at the Morgan Stanley 21st Annual
Global Healthcare Conference on Wednesday, September 13, 2023 at
10:10 a.m. ET, held in New York City.
Access to a live webcast of this event, as well as an archived
recording, will be available under the “Events & Presentations”
tab on the Investors & Media section of the Company’s website
at https://ir.zentalis.com/news-events/events-presentations.
About Zentalis PharmaceuticalsZentalis®
Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company
focused on discovering and developing small molecule therapeutics
targeting fundamental biological pathways of cancers. Utilizing its
Integrated Discovery Engine, the Company is developing a focused
pipeline of potentially best-in-class oncology candidates, which
include azenosertib (ZN-c3), a WEE1 inhibitor for advanced solid
tumors, ZN-d5, a BCL-2 inhibitor for hematologic malignancies and
related disorders, and a heterobifunctional degrader of BCL-xL for
solid and hematological malignancies. The Company is also
leveraging its extensive experience and capabilities across cancer
biology and medicinal chemistry to advance its research on protein
degraders. Zentalis has operations in both New York and San
Diego.
For more information, please visit www.zentalis.com. Follow
Zentalis on Twitter at @ZentalisP and on LinkedIn at
www.linkedin.com/company/zentalis-pharmaceuticals.
Contact:Katie Beach Oltsik Evoke
CanaleKatherine.Beach@evokegroup.com
Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024